Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) closed at $0.28 in the last session, up 1.08% from day before closing price of $0.28. In other words, the price has increased by $1.08 from its previous closing price. On the day, 0.61 million shares were traded. ADAP stock price reached its highest trading level at $0.2864 during the session, while it also had its lowest trading level at $0.2683.
Ratios:
We take a closer look at ADAP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.79 and its Current Ratio is at 2.02.
On July 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.
On May 30, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $3.15.Scotiabank initiated its Sector Outperform rating on May 30, 2024, with a $3.15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 17 ’25 when Norry Elliot sold 5,584 shares for $0.58 per share. The transaction valued at 3,243 led to the insider holds 7,510 shares of the business.
Lunger John sold 5,584 shares of ADAP for $3,243 on Jan 17 ’25. The Chief Patient Supply Officer now owns 7,510 shares after completing the transaction at $0.58 per share. On Jan 17 ’25, another insider, Bertrand William C JR, who serves as the Chief Operating Officer of the company, sold 5,584 shares for $0.58 each. As a result, the insider received 3,243 and left with 7,510 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADAP now has a Market Capitalization of 74082040 and an Enterprise Value of 370340192. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40. Its current Enterprise Value per Revenue stands at 2.062 whereas that against EBITDA is -10.186.
Stock Price History:
The Beta on a monthly basis for ADAP is 2.23, which has changed by -0.76859504 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, ADAP has reached a high of $1.48, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 4.00%, while the 200-Day Moving Average is calculated to be -43.32%.
Shares Statistics:
According to the various share statistics, ADAP traded on average about 931.18K shares per day over the past 3-months and 452190 shares per day over the past 10 days. A total of 257.85M shares are outstanding, with a floating share count of 229.65M. Insiders hold about 10.94% of the company’s shares, while institutions hold 34.04% stake in the company. Shares short for ADAP as of 1749772800 were 4563895 with a Short Ratio of 4.58, compared to 1747267200 on 5834073. Therefore, it implies a Short% of Shares Outstanding of 4563895 and a Short% of Float of 2.09.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
